Press release
Overt Hepatic Encephalopathy Market Set for Rapid Growth During 2021-2026
This report provides critical insights on the market dynamics and enables strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
Market structure: Overview, industry life cycle analysis, supply chain analysis.
Market environment analysis: Growth drivers and constraints
Market segment trend and forecast
Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
Attractive market segments and associated growth opportunities
Key success factors
This report studies the Overt Hepatic Encephalopathy Market and has segmented the market in few ways, keeping in mind the interest of all the stakeholders across the value chain. Following are the ways in which the market is segmented.
Treatment Trends
Based on treatment, the market has been segmented into lactulose, antibiotics, probiotics, liver transplantation, and others. The lactulose segment accounted for the largest market share in 2020. The segment growth can be attributed to its ability to reduce ammonia production in the intestine by creating an aggressive for the bad microbes in the intestine.
Regional Trends
Geographically, the market in North America accounted for the largest market share in 2020 and is expected to continue its dominance over the forecast period owing to an increasing number of people suffering from cirrhosis. For instance, around 5.5 million people in the U.S are affected by cirrhosis and approximately 70% of them are likely to develop symptoms of overt hepatic encephalopathy. The market in the Asia-Pacific region is projected to register the fastest growth during the review period on account of the rising number of people suffering from chronic liver diseases.
Following are the key players in the Overt Hepatic Encephalopathy Market:
• Alfa Wassermann S.P.A (Italy),
• Rebiotix Inc. (The U.S),
• Cosmo Pharmaceuticals S.P.A (Italy),
• Spherium Biomed S.L (Spain),
• Horizon Pharma Plc (Ireland),
• Umecrine Cognition AB (Sweden),
• Ocera Therapeutics Inc. (The U.S),
• Mallinckrodt Pharmaceuticals (UK),
• Kannalife Sciences Inc. (The U.S),
• Bausch Health Companies Inc. (The U.S),
• ASKA Pharmaceutical Co., Ltd (Japan), and
• Norgine BV (Netherlands).
Click Here and Run Through the TOC of the Report:
https://www.stratviewresearch.com/toc/1685/overt-hepatic-encephalopathy-market.html
Highlights from the Report
Hepatic encephalopathy is a brain disorder that most commonly occurs in people having chronic liver disease. Its complications could be dysfunction of the brain and may include impaired memory, intellectual impairment, personality changes, and loss of consciousness (coma). Overt hepatic encephalopathy is associated with obvious, outward signs and symptoms in the affected individuals.
The Overt Hepatic Encephalopathy Market is expected to grow from USD 71.3 million in 2020 to USD 130.6 million by 2026 at a CAGR of over 10.8% during the forecast period.
Reasons to invest in this report -
The report comprises analytical representation of the Overt Hepatic Encephalopathy Market size along with current trends, challenges, and future estimations to depict imminent investment pockets. To understand the profitable trends and gain a stronger foothold, the report also helps the users with key information related to growth drivers, restraints, and opportunities in the market. The current Overt Hepatic Encephalopathy Market forecast is quantitatively analyzed from a particular time period of 5 years to benchmark the financial competency. The user will also get a detailed info about the market trends and share of key vendors.
Read More : https://www.stratviewresearch.com/1685/overt-hepatic-encephalopathy-market.html
400 Renaissance Center,
Suite 2600,
Detroit, Michigan, MI 48243
United States of America
Phone No. +1-313-307-4176
sales@stratviewresearch.com
About Stratview Research-
Stratview Research is a global market intelligence firm having a strong experienced team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. The services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.
Connect with the team –
Call @: +1-313-307-4176
Mail @: sales@stratviewresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Overt Hepatic Encephalopathy Market Set for Rapid Growth During 2021-2026 here
News-ID: 2472556 • Views: …
More Releases from Stratview Research
Satellite Antenna Market to Reach USD 30.0 Billion by 2032, Says Stratview Resea …
The Satellite Antenna Market encompasses antennas used for satellite communications across space, land, maritime, and airborne platforms. The market is forecast to reach USD 30.0 billion by 2032, growing at a CAGR of 19.5 % over the 2025-2032 period. Rapid deployment of Low Earth Orbit (LEO) satellite constellations is the primary growth driver, structurally increasing demand for advanced antennas capable of tracking fast-moving satellites and supporting higher data throughput. This…
Space Robotics Market to Reach USD 6.62 Billion by 2028, says Stratview Research
The Space Robotics Market refers to robotic systems designed to operate in the extreme environments of space, enabling tasks such as satellite servicing, resupply missions, surface mobility, deep space exploration, and in-orbit maintenance with high autonomy and durability. The market was valued at USD 4.43 billion in 2022 and is projected to grow to USD 6.62 billion by 2028 at a CAGR of 6.77% over 2023-2028. The growth is driven…
Electric Vehicle Polymers Market to Reach USD 280.2 Billion by 2030, Says Stratv …
The Electric Vehicle Polymers Market encompasses polymers used in electric cars to reduce vehicle weight while maintaining strength, insulation, and durability. The market is forecast to reach USD 280.2 billion by 2030, up from USD 32.8 billion in 2024, at a 42.3 % CAGR during 2025-2030. The dominant growth driver is the accelerating global adoption of electric vehicles, which structurally increases demand for lightweight, high-performance materials that improve vehicle range…
Ceramic Armor Market to Reach USD 3.84 Billion by 2028, Says Stratview Research
The global Ceramic Armor Market is forecast to grow from an estimated USD 2.34 billion in 2022 to USD 3.84 billion by 2028, expanding at a CAGR of 8.53% during the 2023-2028 period. Ceramic armor-high-hardness, lightweight protective material used in body, vehicle, aircraft, and marine armour-is gaining traction primarily due to rising defense and military expenditure worldwide, which structurally increases demand for advanced protective systems from armed forces and law…
More Releases for Overt
Overt Hepatic Encephalopathy (OHE) Market New Product Development & Latest Trend …
Introduction
Overt Hepatic Encephalopathy (OHE) is a serious and potentially life-threatening complication of chronic liver disease, particularly cirrhosis. It results from the accumulation of neurotoxins, especially ammonia, in the bloodstream, impairing brain function. Patients present with altered mental status, confusion, motor dysfunction, and in severe cases, coma. OHE not only worsens quality of life but also increases hospitalization rates and mortality risk, representing a major healthcare challenge worldwide.
As liver diseases such…
Overt Hepatic Encephalopathy (OHE) Market Emerging Trends and Growth Prospects 2 …
Introduction
Overt Hepatic Encephalopathy (OHE) is a severe neuropsychiatric complication of chronic liver disease, particularly cirrhosis, characterized by altered mental status, confusion, impaired coordination, and, in severe cases, coma. It occurs due to the accumulation of toxins such as ammonia in the bloodstream, which the impaired liver cannot adequately clear. OHE poses a significant healthcare challenge as it leads to frequent hospitalizations, reduced quality of life, and increased mortality.
With the global…
Overt Hepatic Encephalopathy Market Set to Grow at 12.03% CAGR, Reaching USD 106 …
𝐎𝐯𝐞𝐫𝐭 𝐇𝐞𝐩𝐚𝐭𝐢𝐜 𝐄𝐧𝐜𝐞𝐩𝐡𝐚𝐥𝐨𝐩𝐚𝐭𝐡𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰
The global overt hepatic encephalopathy market is experiencing substantial growth, driven by advancements in healthcare technology, increasing liver disease prevalence, and rising awareness about treatment options. According to recent reports, the market was valued at USD XX billion in 2023 and is projected to grow at a CAGR of X.X% from 2024 to 2030, reaching approximately USD XX billion by 2030.
This press release explores country-specific growth,…
Overt Hepatic Encephalopathy Market Trends and Analysis - Opportunities and Chal …
Market Overview and Report Coverage
Overt Hepatic Encephalopathy (OHE) is a severe neurological condition resulting from liver failure, characterized by a spectrum of cognitive and motor dysfunctions, ranging from confusion and forgetfulness to coma. It occurs due to the accumulation of toxins in the bloodstream that the damaged liver cannot adequately process. Recognizing and managing OHE is crucial, as timely intervention can significantly improve patient outcomes.
The current outlook for the Overt…
Overt Hepatic Encephalopathy Treatment Market Size, Share, Industry, Forecast an …
Overt Hepatic Encephalopathy Treatment Market
Global Overt Hepatic Encephalopathy Treatment Market Poised for Significant Growth, Projected High CAGR from 2024-2031
Market Overview:
The global overt hepatic encephalopathy treatment market is anticipated to witness substantial growth, projecting a high Compound Annual Growth Rate (CAGR) during the forecast period from 2024 to 2031. Overt hepatic encephalopathy, a symptomatic impairment of normal brain function resulting from hepatic failure, impacts approximately 40% of cirrhotic patients during…
Overt Hepatic Encephalopathy Treatment Market Size, Share, Industry, Forecast an …
Global Overt Hepatic Encephalopathy Treatment Market Sees Remarkable Growth in 2022 and Projects Impressive CAGR
In the year 2022, the global overt hepatic encephalopathy treatment market achieved a valuation of US$ YY billion, with expectations to reach US$ YY billion by 2030. The market is poised to experience a robust Compound Annual Growth Rate (CAGR) of YY% throughout the forecast period from 2023 to 2030.
The global overt hepatic encephalopathy treatment market…
